 |
|
| COMPREHENSIVE MEDICINAL CHEMISTRY II, EIGHT-VOLUME SET
| |
| | |
|
|
To order this title, and for more information, click here
David Triggle, The State University of New York, Buffalo, USA
John Taylor, Former Senior Vice-President Rhone-Poulenc Rorer, Worldwide, UK
Description
The first edition of Comprehensive Medicinal Chemistry was published in 1990 and was very well received. Comprehensive
Medicinal Chemistry II is much more than a simple updating of the contents of the first edition. Completely revised and expanded,
this new edition has been refocused to reflect the significant developments and changes over the past decade in genomics, proteomics,
bioinformatics, combinatorial chemistry, high-throughput screening and pharmacology, and more. The content comprises the most up-to-date,
authoritative and comprehensive reference text on contemporary medicinal chemistry and drug research, covering major therapeutic classes
and targets, research strategy and organisation, high-throughput technologies, computer-assisted design, ADME and selected case histories.
It is this coverage of the strategy, technologies, principles and applications of medicinal chemistry in a single work that will make Comprehensive Medicinal Chemistry II a unique work of reference and a single point of entry to the literature for pharmaceutical
and biotechnology scientists of all disciplines and for many industry executives as well.
Also available online via ScienceDirect (2006) – featuring extensive browsing, searching, and internal cross-referencing between articles in the work, plus dynamic linking to journal
articles and abstract databases, making navigation flexible and easy. For more information, pricing options and availability visit www.info.sciencedirect.com.
Audience
New and experienced scientists of all disciplines concerned with drug research in both academia and industry, including medicinal chemists,
organic chemists, biochemists, biologists, and pharmacologists; students, scientists teaching medicinal chemistry; researchers and executives
in the pharmaceutical and biotechnology industry.
Contents
Volume 1 Global Perspective (P. Kennewell).
Volume 2 Research and Development (W.H. Moos).
Volume 3 Technologies (H. Kubinyi).
Volume 4 Computer-Assisted Drug Design (J.S. Mason).
Volume 5 ADME-Tox Approaches (B. Testa and H. van de Waterbeemd).
Volume
6 Therapeutic Areas I (M. Williams).
Volume 7 Therapeutic Areas II (J. Plattner and M.C. Desai).
Volume 8 Case Histories and
Cumulative Subject Index (J.B. Taylor and D.J. Triggle).
| Bibliographic details |
Hardbound, 7200 pages, publication date: NOV-2006
ISBN-13: 978-0-08-044513-7
ISBN-10: 0-08-044513-6
Imprint: ELSEVIER
|
| Price and Ordering |
Price:
GBP 2,636.90
USD 6,550
EUR 2,908.50
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
030/302
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company